Cargando…

SUN-443 Surgical Management of Cystic Prolactinomas

Purpose: Treatment of prolactinomas with a predominantly cystic component remains controversial. This study assessed remission rates in surgically-treated cystic prolactinomas, compared to solid micro- and macroprolactinomas. Methods: Charts were retrospectively analyzed for 57 patients who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nevzati, Edin, Chatain, Gregoire, Carr, Steven, Lillehei, Kevin, Kerr, Janice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553453/ http://dx.doi.org/10.1210/js.2019-SUN-443

Ejemplares similares

SUN-447 Screening of Genetic Alterations in Patients with Giant Prolactinomas
por: Chaves, Carolina, et al.
Publicado: (2019)

SUN-LB073 Giant Prolactinomas: Recidive (Case Report)
por: Galesanu, Corina
Publicado: (2019)

SUN-442 EGFR/ErbB2 Targeted Therapy for Aggressive Prolactinomas
por: Cooper, Odelia, et al.
Publicado: (2019)

SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists
por: Mallea Gil, Susana, et al.
Publicado: (2019)

MON-443 Periostin Concentrations in Childhood-Onset Craniopharyngioma Patients
por: Heinks, Kerstin, et al.
Publicado: (2019)

SUN-445 A Brazilian Multicentric Study Evaluating Pregnancies Induced by Cabergoline in Patients Harboring Prolactinomas
por: Sant Anna, Beatriz, et al.
Publicado: (2019)

ODP364 Prolactinomas in men: management challenges
por: Baciu, Ionela, et al.
Publicado: (2022)

SAT-478 Successful Management of an Atypical Prolactinoma with Radiotherapy
por: Bowes, Christa, et al.
Publicado: (2019)

Cerebrospinal Fluid Leak After Medical Management of Prolactinoma
por: Pechman, Amanda, et al.
Publicado: (2021)

Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding
por: Dawaher, Wafa, et al.
Publicado: (2021)

SAT616 Differentiating Resistant Prolactinoma From Macroprolactinemia
por: Lacount, Steven, et al.
Publicado: (2023)

Giant Prolactinoma Causing Proptosis and Stroke
por: Wortham, Joy, et al.
Publicado: (2021)

MON-324 Management and Therapeutic Response Comparison in Prolactinomas According to Tumor Size
por: Flores-Cardenas, Romina
Publicado: (2020)

Giant Prolactinomas: An Experience From South India
por: S, Vishwanath, et al.
Publicado: (2021)

FRI306 Natural History Of Untreated Prolactinoma
por: Sadek, Maryanne, et al.
Publicado: (2023)

SAT623 Everolimus For Treatment-refractory Prolactinomas
por: Lin, Andrew L, et al.
Publicado: (2023)

MON-266 The Association Between Prolactinomas and Weight Gain
por: Tariq, Zunera, et al.
Publicado: (2020)

FRI314 Prolactinoma And Macroprolactin; A Diagnostic Dilemma
por: Farooqi, Aneeba, et al.
Publicado: (2023)

FRI296 Somatostatin Receptor 5 Staining In Prolactinomas
por: Mehta, Sonal, et al.
Publicado: (2023)

SAT612 Granulomatous Mastitis: An Unusual Presentation Of Prolactinoma
por: Alkaissi, Hussam R, et al.
Publicado: (2023)

FRI320 The Various Clinical Outcomes Of Giant Prolactinomas In Men
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2023)

FRI323 Prolactinoma Recurrence With Testosterone Treatment In Transgender Male
por: Arnouk, Nelly, et al.
Publicado: (2023)

SAT-443 Osilodrostat Has No Clinically Relevant Effect on the Pharmacokinetic (PK) Profile of a Monophasic Oral Contraceptive in Healthy Females Receiving Cortisol Replacement Therapy
por: Breitschaft, Astrid, et al.
Publicado: (2019)

SAT-466 Cases of Acromegaly and Presumed Prolactinoma in Setting of Empty Sella Syndrome: Presentation and Management Implications
por: Uwaifo, Gabriel
Publicado: (2019)

Prolactinoma in Two Brothers - Unidentified Genetic Cause Versus Co-Incidence?
por: Gundluru, Rajani, et al.
Publicado: (2021)

FRI300 Prolactinoma And Pregnancy: A Systematic Review And Meta-analysis
por: Bandeira, Diego Barata, et al.
Publicado: (2023)

FRI316 A Rare Case Of Mono-hormonal Silent Prolactinoma
por: Esaki, Yumiko, et al.
Publicado: (2023)

Clinical Correlation to E-cadherin and Granulation Patterns in Corticotroph Tumors
por: Lipe, Kristin A, et al.
Publicado: (2021)

PMON169 D2R Expression in Dopamine-Agonist Resistant Prolactinomas
por: Levine, Alice, et al.
Publicado: (2022)

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2023)

SAT604 An Extensively Invasive Giant Prolactinoma Associated With CDH23 Mutation
por: Alghamdi, Balgees, et al.
Publicado: (2023)

SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019)

SAT-246 A Case of Cabergoline Induced Pituitary Apoplexy in a Patient with Prolactinoma
por: Ahuja, Ashim
Publicado: (2020)

Recovery of Male Hypogonadism Following Successful Treatment of Prolactinoma: The Experience of an Integrated Health Network
por: Voica, Mihail, et al.
Publicado: (2021)

PSUN343 Ectopic Prolactinoma in the Bony Clivus: A Common Disease in an Uncommon Location
por: Eisenberg, Yuval, et al.
Publicado: (2022)

THU100 Case Of A Large Suprasellar-clival Mass: Prolactinoma Vs Paraganglioma
por: Madera Marin, Luis Norberto, et al.
Publicado: (2023)

SAT620 Dopamine Challenge: Treatment Of Pituitary Macroadenoma/Prolactinoma In Patient On Antipsychotic Medication
por: Bazhenov, Aleksei, et al.
Publicado: (2023)

FRI321 Aggressive Prolactinoma Empirically Treated With Cabergoline Leading To Rapid CSF Leak
por: Yau, Alice, et al.
Publicado: (2023)

SAT-247 Use of Double Dopamine Agonists in Giant Prolactinomas: A Series of 6 Cases
por: Kuan, Yueh Chien
Publicado: (2020)

MON-293 The Prevalence of Impulse Control Disorders in Patients with Acromegaly and Prolactinomas Treated with Dopamine Agonists
por: Ozkaya, Hande Mefkure, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3suevknk6gsrfq450k0pdq1ftj